Activity Description
This activity provides an overview of current HIV prevention and treatment options with a focus on tailoring care to the needs and preferences of LGBTQ individuals. Participants will explore patient-centered approaches to sexual history-taking, age-specific care considerations, and integration of STI prevention strategies, including DoxyPEP, into comprehensive HIV prevention planning.
Target Audience
This activity is intended for Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
-
Media: Enduring Material
-
Release date: 06/15/2026
-
Expiration date: 06/15/2028
-
Time to Complete: 45 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the range of current HIV prevention and treatment options.
- Demonstrate approaches to assessing patient preferences and needs through sexual health history-taking.
- Identify appropriate HIV interventions for patients of various ages and demographics, including youth.
- Integrate STI prevention strategies, such as DoxyPEP, into HIV prevention planning based on exposure risk and clinical guidance.
Accreditation, Credit, and Support
Participants can earn up to 0.75 credits/contact hours (CME, AAPA, ANCC, CPE) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 06/15/2028.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
JA4008396-0000-26-030-H02-P
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Asia Sullivan, PA-C, MPH
Physician Associate
Suite 401 Medical
Los Angeles, CA
Disclosure: has disclosed the following relevant financial relationships with ineligible companies:
– Speaker or member of a speaker’s bureau for: GSK
– Advisor, Consultant, or Independent Contractor for Gilead Sciences and GSK
All relevant financial relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Joseph Cherabie, MD, MSc
Medical Director
St. Louis STI/HIV Prevention Training Center
St. Louis, MO
Disclosure: Joseph Cherabie has disclosed the following relevant financial relationship with an ineligible company:
– Advisor, Consultant, or Independent Contractor for Gilead and Innoviva Pharmaceuticals
This relationship has been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.
Activity Description
This activity examines the structural and systemic barriers LGBTQ individuals face when accessing HIV prevention and care services. Participants will review evidence-based strategies for improving access, such as navigation support, inclusive care models, and approaches to address stigma, documentation, and insurance-related challenges.
Target Audience
The target audience for this program is primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Media: Enduring Material
Release date: June 16, 2026
Expiration date: June 16, 2028
Time to Complete: 45 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
- Recognize the impact of stigma, mistrust, and systemic healthcare barriers on LGBTQ individuals.
- Identify evidence-based approaches to improve access, such as navigation support and inclusive care practices.
- Discuss structural barriers including documentation, insurance, and provider bias and strategies to address them.
Accreditation, Credit, and Support
Participants can earn up to 0.75 credits/contact hours (CME, AAPA, ANCC, CPE) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 06/16/2028.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
JA4008396-0000-26-033-H02-P
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, have been reviewed for relevant financial relationships with ineligible companies. Any identified relevant financial relationships have been mitigated in accordance with the Standards for Integrity and Independence in Accredited Continuing Education.
These relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Faculty Disclosure
Hyman Scott, MD, MPH,
University of California, San Francisco (UCSF),
San Francisco, CA
Disclosure: Hyman Scott has disclosed the following relevant financial relationships with ineligible companies:
– Recipient of research support from: Gilead Sciences
All relevant financial relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must complete the entire CE activity, complete the post-test and activity evaluation form, and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.
Activity Description
This module provides critical insights into culturally grounded strategies and equity-focused models that improve health outcomes and re-engage communities historically excluded from mainstream healthcare systems.
Target Audience
The target audience for this program is primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Media: Enduring Material
Release date: June 16, 2026
Expiration date: June 16, 2028
Time to Complete: 45 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the rationale for prioritizing same-gender-loving Black and Latino men in HIV prevention and care
- Identify key social determinants of health affecting HIV prevention and care in same-gender-loving Black and Latino men
- Evaluate the effectiveness of culturally grounded and community-led care models on HIV prevention and treatment
- Describe the implications of underrepresentation in HIV clinical trials for same-gender-loving Black and Latino men
Accreditation, Credit, and Support
Participants can earn up to 0.75 credits/contact hours (CME, AAPA, ANCC, CPE) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 06/16/2028.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
JA4008396-0000-26-035-H02-P
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, have been reviewed for relevant financial relationships with ineligible companies. Any identified relevant financial relationships have been mitigated in accordance with the Standards for Integrity and Independence in Accredited Continuing Education.
These relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Faculty Disclosure
Orlando Harris, PhD, FNP, MPH,
UCSF, San Francisco, CA
Disclosure: Orlando Harris has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must complete the entire CE activity, complete the post-test and activity evaluation form, and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.
Activity Description
Providing Optimal HIV Care to Transgender and Gender Diverse Persons is the fourth module in the LGBTQ Equity in HIV Prevention and Treatment Series. Join Asa Radix, MD, PhD, MPH, as they explore best practices in delivering gender-affirming, patient-centered HIV prevention and treatment. Additionally, Dr. Radix will also provide critical insights into reducing barriers to care, integrating inclusive clinical practices, and addressing the unique health needs of transgender and gender diverse communities across the HIV care continuum.
Target Audience
The target audience for this program is primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Media: Enduring Material
Release date: June 16, 2026
Expiration date: June 16, 2028
Time to Complete: 45 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify core epidemiologic and clinical considerations relevant to transgender and gender diverse non-conforming patients
- Apply strategies for inclusive and affirming HIV care environments
- Recognize the impact of gender-affirming care in facilitating HIV engagement
Accreditation, Credit, and Support
Participants can earn up to 0.75 credits/contact hours (CME, AAPA, ANCC, CPE) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 06/16/2028.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
JA4008396-0000-26-036-H02-P
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, have been reviewed for relevant financial relationships with ineligible companies. Any identified relevant financial relationships have been mitigated in accordance with the Standards for Integrity and Independence in Accredited Continuing Education.
Faculty Disclosure
Asa Radix, MD, PhD, MPH,
Callen-Lorde, New York, NY
Disclosure: Asa Radix has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must complete the entire CE activity, complete the post-test and activity evaluation form, and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.
Activity Description
Addressing HIV and Overall Care Needs and Coordination Among Older Gay and Bisexual Men is the fifth module in the LGBTQ Equity in HIV Prevention and Treatment Series. Join Aniruddha Hazra, MD, as he examines the intersection of aging, HIV, and broader health needs for older gay and bisexual men, with a focus on care coordination and long-term wellness. Additionally, Dr. Hazra will also provide critical insights into managing comorbidities, addressing social and mental health challenges, and strengthening interdisciplinary approaches to ensure holistic, affirming care for aging gay and bisexual men living with or at risk for HIV.
Target Audience
The target audience for this program is primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Media: Enduring Material
Release date: June 16, 2026
Expiration date: June 16, 2028
Time to Complete: 45 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
- Recognize aging-related health and social challenges in older LGBTQ adults
- Apply strategies for integrated and geriatric-informed HIV care
- Address social isolation, mental health, and long-term prevention needs
Accreditation, Credit, and Support
Participants can earn up to 0.75 credits/contact hours (CME, AAPA, ANCC, CPE) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 06/16/2028.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
JA4008396-0000-26-037-H02-P
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, have been reviewed for relevant financial relationships with ineligible companies. Any identified relevant financial relationships have been mitigated in accordance with the Standards for Integrity and Independence in Accredited Continuing Education.
Faculty Disclosure
Aniruddha Hazra, MD,
UChicago Medicine, Chicago, IL
Disclosure: Aniruddha Hazra has disclosed the following relevant financial relationships with ineligible companies:
– Advisor, Consultant, or Independent Contractor for Gilead Sciences and ViiV Healthcare
– Recipient of research funding from Gilead Sciences
All relevant financial relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education."
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must complete the entire CE activity, complete the post-test and activity evaluation form, and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.